Cas:54167-89-4 N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide manufacturer & supplier

We serve Chemical Name:N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide CAS:54167-89-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide

Chemical Name:N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide
CAS.NO:54167-89-4
Synonyms:N-(2-amino-4-phenyl-1,3-thiazol-5-yl)acetamide
Molecular Formula:C11H11N3OS
Molecular Weight:233.29000
HS Code:2934100090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:474.1ºC at 760 mmHg
Density:1.35g/cm3
Index of Refraction:1.687
PSA:96.25000
Exact Mass:233.06200
LogP:3.00490

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like N-(2-amino-4-phenyl-1,3-thiazol-5-yl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-amino-4-phenyl-1,3-thiazol-5-yl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2-amino-4-phenyl-1,3-thiazol-5-yl)acetamide Use and application,N-(2-amino-4-phenyl-1,3-thiazol-5-yl)acetamide technical grade,usp/ep/jp grade.


Related News: RELATED: CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide manufacturer International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide supplier All of China��s provinces and territories have now been touched by the outbreak. N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide vendor All of China��s provinces and territories have now been touched by the outbreak. N-(2-Amino-4-phenyl-1,3-thiazol-5-yl)acetamide factory Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.